Brain stimulation coils for depression treatment

Unlocking Depression Treatment: Are Two Brain Stimulation Coils Better Than One?

"A new study reveals significant differences in motor threshold between figure-8 and double-cone coils for rTMS, offering potential for personalized depression therapy."


Transcranial Magnetic Stimulation (TMS) is emerging as a pivotal tool in the treatment of refractory depression, offering hope to those who haven't found relief through traditional methods. TMS involves using magnetic fields to stimulate nerve cells in the brain to alleviate depression symptoms. The figure-8 (Fo8) coil and the double cone (DC) coil are two common types of coils used in TMS therapy. Each coil has unique characteristics that affect how it stimulates the brain.

The figure-8 coil is known for its ability to deliver a superficially focal stimulation, concentrating the magnetic field on a specific area of the brain's surface. This precision can be particularly useful when targeting specific cortical regions believed to be involved in depression. In contrast, the double cone coil is designed to reach deeper brain structures. While it offers less focal stimulation, it can activate a larger volume of cortical tissue, making it a valuable alternative for patients who may benefit from broader stimulation.

Recent research conducted at the Centre Hospitalier de l'Université de Montréal (CHUM) has shed light on the differences between these two coils. The study revealed significant variations in motor thresholds (MTs) when using the Fo8 and DC coils in patients with refractory depression. This finding could have profound implications for how TMS therapy is administered and tailored to individual patients.

Decoding Motor Thresholds: Why Coil Choice Matters in rTMS

Brain stimulation coils for depression treatment

Motor threshold (MT) is a crucial parameter in TMS, representing the minimum intensity of stimulation required to produce a motor response. Determining MT accurately is essential for ensuring that patients receive the appropriate dose of stimulation during TMS therapy. Too little stimulation may be ineffective, while too much can lead to adverse effects.

The CHUM study, led by Jean-Philippe Miron and colleagues, sought to investigate the differences in MTs between the Fo8 and DC coils in patients with refractory depression. Nine patients were recruited for the study, and their MTs were measured using both coils during the same session. A counterbalancing design was employed to minimize any potential inhibitory effects on cortical excitability.

  • Significant MT Differences: The study found a significant difference in MTs between the two coils. The average MT with the Fo8 coil was 57.9%, while the average MT with the DC coil was 39.7%.
  • Higher MTs with Fo8: On average, the MT was 31.5% higher for the Fo8 coil compared to the DC coil. This means that a greater intensity of stimulation was needed to elicit a motor response with the Fo8 coil.
  • Correlation Between Coils: The researchers observed a positive correlation between the MTs of the two coils. As the MT with the Fo8 coil increased, the difference in cortical activation capacity between the coils also increased.
These findings suggest that the choice of coil can significantly impact the amount of stimulation required to achieve the desired therapeutic effect. Clinicians need to be aware of these differences when determining MT and administering TMS therapy. Using the MT obtained with one coil for treatment with another coil could result in under- or over-stimulation, potentially affecting treatment outcomes and safety.

Personalizing Depression Therapy: The Future of rTMS

The CHUM study highlights the importance of individualizing TMS therapy based on coil type and patient characteristics. The significant differences in MTs between the Fo8 and DC coils suggest that a one-size-fits-all approach may not be optimal. By carefully considering the coil type and adjusting stimulation parameters accordingly, clinicians can potentially improve treatment outcomes and minimize adverse effects. Future research should focus on further elucidating the factors that influence MT and optimizing TMS protocols for different patient populations. This will pave the way for more effective and personalized depression therapy.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

What is Transcranial Magnetic Stimulation (TMS), and how is it used in treating depression?

Transcranial Magnetic Stimulation, or TMS, is a method used to treat depression that hasn't responded to other treatments. It uses magnetic fields to stimulate brain nerve cells, which can alleviate depression symptoms. The figure-8 coil and the double cone coil are two types of coils used in TMS therapy, each having unique characteristics that affect how it stimulates the brain. TMS is emerging as an important tool for individuals with refractory depression offering hope to those who haven't found relief through traditional methods.

2

What are the key differences between the figure-8 coil and the double cone coil in TMS therapy?

The figure-8 coil delivers stimulation in a superficially focal manner, concentrating the magnetic field on a specific area of the brain's surface. This precision is particularly useful for targeting specific cortical regions believed to be involved in depression. The double cone coil is designed to reach deeper brain structures. While it offers less focal stimulation, it can activate a larger volume of cortical tissue, making it a valuable alternative for patients who may benefit from broader stimulation. The choice of coil can significantly impact the stimulation required to achieve the desired therapeutic effect.

3

What is 'motor threshold' (MT), and why is it important in TMS?

Motor threshold, or MT, is the minimum intensity of stimulation required to produce a motor response during TMS. Determining MT accurately is essential for ensuring that patients receive the appropriate dose of stimulation during TMS therapy. Too little stimulation may be ineffective, while too much can lead to adverse effects. The accurate determination of MT using the appropriate coil is paramount to safe and effective treatment.

4

What did the research reveal about the differences in motor thresholds (MTs) between the figure-8 and double cone coils?

Research indicates a significant difference in motor thresholds (MTs) when using the figure-8 (Fo8) and double cone (DC) coils in patients with refractory depression. On average, the MT was 31.5% higher for the Fo8 coil compared to the DC coil. Clinicians need to be aware of these differences when determining MT and administering TMS therapy. Using the MT obtained with one coil for treatment with another coil could result in under- or over-stimulation, potentially affecting treatment outcomes and safety.

5

Why is personalized therapy important in rTMS, and how do the figure-8 and double cone coils play a role?

The differences in MTs between the figure-8 and double cone coils suggest that a one-size-fits-all approach may not be optimal. Clinicians can potentially improve treatment outcomes and minimize adverse effects by carefully considering the coil type and adjusting stimulation parameters accordingly. Future research should focus on further elucidating the factors that influence MT and optimizing TMS protocols for different patient populations to make way for more effective and personalized depression therapy. This will lead to individual treatments based on the specific needs of the patient.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.